Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance
Cancers · 09.03.2023 · 15 (6) · 1682
DOI: 10.3390/cancers15061682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 09.03.2023. Verfasst von Philip Weir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Belfast City Hospital, Belfast BT9 7AB, UK. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leukaemia & Lymphoma NI, Leukaemia and Lymphoma NI.
Abstract (Originalsprache)
Despite significant improvements in treatment strategies over the past couple of decades, multiple myeloma (MM) remains an incurable disease due to the development of drug resistance. Metabolic reprogramming is a key feature of cancer cells, including MM, and acts to fuel increased proliferation, create a permissive tumour microenvironment, and promote drug resistance. This review presents an overview of the key metabolic adaptations that occur in MM pathogenesis and in the development of resistance to proteasome inhibitors, the backbone of current MM therapy, and considers the potential for therapeutic targeting of key metabolic pathways to improve outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, Belfast City Hospital, Belfast BT9 7AB, UK.
- Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.
- Centre for Medical Education, Queen's University Belfast, Belfast BT9 7BL, UK.
ORCID-Profile: Mary Frances McMullin, Lisa Crawford
Förderung
- Leukaemia & Lymphoma NI
- Leukaemia and Lymphoma NI
Zitieren
APA
Weir, P., Donaldson, D., McMullin, M. F., & Crawford, L. (2023). Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance. Cancers, 15(6), 1682. https://doi.org/10.3390/cancers15061682
Vancouver
Weir P, Donaldson D, McMullin MF, Crawford L. Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance. Cancers. 2023;15(6):1682. doi:10.3390/cancers15061682
BibTeX
@article{Weir2023,
author = {Weir, Philip and Donaldson, David and McMullin, Mary Frances and Crawford, Lisa},
title = {Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance},
journal = {Cancers},
year = {2023},
volume = {15},
number = {6},
pages = {1682},
doi = {10.3390/cancers15061682}
}
EUVIMED